First Successful Conception Induced by a Male Cystinosis Patient by Veys, K.R. et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2019-06-01 and may be subject to
change.
RESEARCH REPORT
First Successful Conception Induced by a Male
Cystinosis Patient
Koenraad R. Veys • Kathleen W. D’Hauwers •
Angelique J. C. M. van Dongen • Mirian C. Janssen •
Martine T. P. Besouw • Ellen Goossens •
Lambert P. van den Heuvel • Alex A. M. M. Wetzels •
Elena N. Levtchenko
Received: 03 January 2017 /Revised: 06 March 2017 /Accepted: 09 March 2017 /Published online: 13 April 2017
# SSIEM and Springer-Verlag Berlin Heidelberg 2017
Abstract Cystinosis is a rare autosomal recessive lyso-
somal storage disease characterized by multi-organ cystine
accumulation, leading to renal failure and extra-renal organ
dysfunction. Azoospermia of unknown origin is the main
cause of infertility in all male cystinosis patients. Although
spermatogenesis has shown to be intact at the testicular
level in some patients, no male cystinosis patient has been
reported yet to have successfully induced conception.
We present the first successful conception ever reported,
induced by a 27-year-old male renal transplant infantile
nephropathic cystinosis patient through percutaneous epi-
didymal sperm aspiration (PESA) followed by intracyto-
plasmatic sperm injection (ICSI). After 36 weeks and
6 days of an uncomplicated pregnancy, a dichorial
diamniotic (DCDA) twin was born with an appropriate
weight for gestational age and in an apparently healthy
status. Moreover, we demonstrate that the sperm of
epididymal origin in selected male cystinosis patients can
be viable for inducing successful conception.
Our observation opens a new perspective in life for
many male cystinosis patients whom nowadays have
become adults, by showing that despite azoospermia
fathering a child can be realized. In addition, our findings
raise questions about the possibility of sperm cryopreserva-
tion at a young age in these patients.
Introduction
Cystinosis (OMIM #219800) is a rare, autosomal recessive
lysosomal storage disease, caused by mutations in the
CTNS gene encoding cystinosin, a lysosomal proton-cystine
cotransporter (Town et al. 1998). It is characterized by
lysosomal cystine accumulation and crystal formation in all
organs and tissues (Town et al. 1998; Gahl et al. 2002).
The disease initially affects the kidneys, causing renal
Fanconi syndrome in early childhood, and progresses to
end-stage renal disease in puberty or early adulthood.
However, during the first decades of life, various endocrine
organs can also be affected (Chan et al. 1970; Fivush et al.
1987, 1988). In addition to primary hypothyroidism,
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growth retardation, and pancreatic insufficiency, hyper-
gonadotropic hypogonadism has been reported as a fre-
quent finding in male cystinosis patients (Chik et al. 1993).
As of yet, in contrast to a few female patients who have
given birth, no male cystinosis patient is known to have
induced pregnancy. More recently, it was shown that this
infertility in male cystinosis patients is due to azoospermia
of yet unknown origin (Besouw et al. 2010).
Treatment with the cystine-depleting drug cysteamine
delays the onset of end-stage renal disease and prevents
multi-organ damage (Markello et al. 1993; Brodin-Sartorius
et al. 2012). While first described in 1976 (Thoene et al.
1976), the use of cysteamine in cystinosis patients only
became widespread in the early 1990s with the availability
of the commercial preparation of cysteamine bitartrate
(Cystagon®) (Schneider et al. 1995). Currently, a growing
population of cystinosis patients who were treated with
cysteamine starting from infancy or early childhood is
reaching young adulthood. This prolonged life expectancy
raises novel quality of life issues such as male infertility.
Here, for the first time ever, we report a successful
conception induced by epididymal sperm of a male
cystinosis patient through assisted reproductive technology
(ART).
Case Report
A 27-year-old male nephropathic cystinosis patient and his
wife were consulted at the fertility clinic for realizing their
wish of having children.
The patient was formerly diagnosed with nephropathic
cystinosis at the age of 4 years when he presented with
renal Fanconi syndrome and photophobia. Slit lamp
examination revealed the presence of corneal cystine
crystals. The diagnosis of cystinosis was confirmed by
genetic analysis of the CTNS gene showing a compound
heterozygous mutation (the common 57 kb deletion on one
allele, and a point mutation in the lariat branch site of intron
4: c.141-24T>C on the other allele). The latter mutation
results in skipping of exon 5 during transcription (Taranta
et al. 2010). The leucocyte cystine level at the moment of
diagnosis was 7.8 nmol 1/2 cystine/mg protein. Ever since
the initiation of treatment, the total dose of cysteamine has
been between 1.3 and 1.9 g/m2/day. End-stage renal disease
was developed by the age of 10 years requiring renal
replacement therapy (RRT) in the form of peritoneal
dialysis. Deceased donor kidney transplantation was fol-
lowed at the age of 11. The immunosuppressive regimen
consisted of ciclosporin A, azathioprine, and low-dose
prednisone. Both growth and pubertal development were
delayed. At the age of 15, the Tanner stages of puberty
were A1P2G2. Height was 153.5 cm, which is below
2 standard deviations (SD), and bone age lagged behind
2 years in comparison to calendar age. Recombinant human
growth hormone (rhGH) therapy was initiated after kidney
transplantation and resulted in a catch-up growth and a final
height of 176 cm. At the age of 18 years, the patient
reached a full sexual maturation with Tanner stage 5 and a
final bilateral testes volume of 18 mL with a normal
consistence. In addition, thyroid function tests always
remained within the normal range. Until now, no signs of
renal transplant rejection have ever occurred and current
eGFR is 110 mL/min/1.73 m2.
A previous fertility status evaluation at the age of
21 years showed normal levels of FSH, LH, testosterone,
and inhibin B (Table 1, first column). However, no sperm
was present in the ejaculate obtained by masturbation,
which led to the diagnosis of azoospermia.
Following the consultation at the fertility clinic, the
pituitary-testicular axis hormonal status was reassessed
Table 1 Hormonal levels of the pituitary-testicular axis in the reported male cystinosis patient
Ref. value
Age (years) 21 22 22 23 26 27
FSH (U/L) 1.5–11.0 7.79 5.5 6.3 7.4 8.3 8.4
Inhibin B (pg/L) 150–400 210 174
LH (U/L) 1.4–8.5 7.44 4.6 7.4 10.0a 7.4 7.3
Testosterone (nmol/L) 11–45 16 9.5 21.6 30.3 15 17
Creatinine (mmol/L) 60–110 83 96 93 100 109 115
Leucocyte cystine level (nmol 1/2 cystine/mg protein) <1 0.96 2.9 2.42 1.42 2.14 0.78
Cysteamine dose 1,050 mg qid
Results are reported from the first fertility assessment at the age of 21 years (first column; reported as patient 2 in Besouw et al. (2010)), until the
assessment at the age of 27 years prior to the first percutaneous epididymal aspiration (PESA) procedure (last column)
a Above the upper normal limit. Based on these results, no primary hypogonadism can be observed. The ejaculate showed azoospermia at the age
of 21 and 27 years (data not shown)
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(Table 1, last column). Because of proven azoospermia, and
in order to avoid complications related to testicular sperm
extraction (TESE), a percutaneous epididymal sperm
aspiration (PESA) was performed. The funiculus was
anesthetized with prilocaine hydrochloride (Citanest®) and
0.25 mL of epididymal fluid was aspirated on the left side,
and 0.5 mL on the right side. This procedure revealed the
bilateral presence of mature spermatozoa. In total, from the
left epididymis 0.2  106 spermatozoa were harvested
(0.80  106/mL); the right epididymis yielded 2.5  106
spermatozoa (5.0  106/mL). In both sides, 1% of the
spermatozoa showed progressive motility, and 8% showed
nonprogressive motility. The sperm was mixed with Test
Yolk Buffer (Irvine Scientific, USA) and cryopreserved in
abidance of an intracytoplasmatic sperm injection (ICSI)
procedure.
In the first ICSI attempt, two oocytes (metaphase II)
were obtained, of which one was fertilized. In the second
attempt, six out of seven oocytes were fertilized. Single
embryo transfer did not result into pregnancy and cryopres-
ervation of the remaining embryos was not possible due to
insufficient quality.
A new PESA procedure was performed before the third
ICSI attempt. Fifty thousand spermatozoa were obtained
from the right epididymis (aspirated total epididymal fluid:
0.5 mL; concentration of spermatozoa: 0.10  106/mL),
with 12% progressive and 14% nonprogressive motility.
The semen was again cryopreserved. In the third attempt,
eight oocytes could be obtained of which six were
fertilized. Double embryo transfer was followed on day 3.
One embryo was suitable for cryopreservation on day 5
(blastocyst). Two weeks later, a pregnancy test resulted
positive, and at 7 weeks of gestation an intact dichorial
diamniotic (DCDA) twin was identified by ultrasound.
Pregnancy was monitored in a regional hospital and at a
gestational age of 36 weeks and 6 days the DCDA twin was
born via an uncomplicated caesarean section. Both
newborns were apparently healthy with respective birth
weights of 2,910 g (son) and 2,884 g (daughter). Subse-
quently, DNA analysis of the cord blood showed the
heterozygous c.141-24T>C mutation in the CTNS gene in
both offspring, confirming the paternity of our cystinosis
patient.
Discussion
Over the last few decades, the advent and progress in
cystine-depleting treatment and RRT have significantly
improved the prognosis of cystinosis patients (Gahl et al.
2002; Markello et al. 1993; Brodin-Sartorius et al. 2012).
As a result of earlier diagnosis, rapid initiation of adequate
cysteamine therapy, and improved therapeutic monitoring,
the life expectancy of cystinosis patients has been greatly
extended, allowing them nowadays to survive into adult-
hood.
This favorable evolution has created a new perspective,
raising specific adult-related issues. Hence, being one of the
essential human needs and major determinants of quality of
life, having children has become a matter of concern to
adult cystinosis patients and their families.
Here, for the first time, we report a successful conception
induced by a male cystinosis patient through ART with
PESA followed by ICSI. The paternity of our patient could
be confirmed as both offspring inherited the rare heterozy-
gous mutation in the CTNS gene, which has only been
described in the index case and his sister thus far (Taranta
et al. 2010). In addition to the previous report of Besouw
et al. which has shown intact spermatogenesis at the
testicular level (Besouw et al. 2010), we demonstrate for
the first time that the sperm of epididymal origin can be
viable in selected male cystinosis patients and can be used
for inducing conception successfully.
To this date, the exact pathophysiology of the primary
hypogonadism and azoospermia observed in patients with
cystinosis is not yet fully understood. In a first organized
report on reproductive function in male infantile nephro-
pathic cystinosis patients after renal transplantation pub-
lished in 1993, hypergonadotropic hypogonadism was
shown to be present in the majority of patients (70%)
(Chik et al. 1993). This finding could neither be explained
by the effect of the previous chronic renal insufficiency nor
by renal transplantation and immunosuppressive agents
used in the established regimens. In a more recent study, the
pituitary-testicular axis remained within normal limits in a
subset of male patients although azoospermia was present
in all of them (Besouw et al. 2010). Surprisingly, a
testicular biopsy in one of these patients showed an intact
spermatogenesis (Johnsen score 8–9) (Besouw et al. 2010;
Johnsen 1970). As azoospermia was also present in patients
treated with cysteamine starting from early age, it remained
uncertain whether cysteamine had no therapeutic effect on
the pathophysiology of azoospermia, or the drug itself
would be involved in causing infertility. In addition, as
azoospermia was documented in some patients in the
presence of a normal renal function (eGFR), altered renal
function cannot be regarded as a major determinant of
fertility status (Besouw et al. 2010).
Some hypothetical causes for this azoospermia in
nephropathic cystinosis patients with a normal pituitary-
testicular axis and renal function can be suggested. First, as
spermatogenesis at the testicular level has shown to be
intact, it could be hypothesized that epididymal sperm
maturation is altered. Epididymal sperm maturation is a
process in which spermatozoa acquire their motility and
fertilizing capacity during transit from caput to cauda
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epididymis (Dacheux and Dacheux 2013). This is a crucial
step in the establishment of male fertility. Herein, the
composition and changing biochemical properties (water,
sodium, potassium, bicarbonate, pH, calcium, and osmolal-
ity) of the epididymal luminal fluid play a vital role
(Dacheux and Dacheux 2013; Pholpramool et al. 2011;
Pastor-Soler et al. 2005; Weissgerber et al. 2011). The renal
proximal tubule and the epididymis share the same
embryonic precursor – the intermediate mesoderm – both
are highly metabolically active and serve a shared goal of
maintaining electrolyte and acid–base homeostasis through
similar transepithelial transport processes. Therefore,
although – in contrast to the renal proximal tubule – the
sensitivity of epididymal tubular epithelial cells to cystino-
sin dysfunction is unknown, one could speculate that
epididymal transepithelial electrolyte transport in cystinosis
is impaired. Indeed, altered acidification of the epididymal
luminal fluid milieu has been recognized as a cause of
infertility (Pholpramool et al. 2011; Pastor-Soler et al.
2005). In addition, although the exact role of the epididy-
mal luminal Ca2+ is not fully clear, the motility and
viability of sperm of the cauda epididymis was markedly
reduced in a vanilloid type transient receptor potential
cation channel 6 knock-out (trpv6/) murine model, in the
presence of abnormal high calcium concentrations in the
intraluminal fluid of the cauda epididymis (Weissgerber
et al. 2011).
Second, in vivo and in vitro data on cysteamine, being
the only available disease-modifying drug, suggest an
indirect local as well as a systemic endocrine effect, the
latter through actions of ghrelin. Via inhibition of somato-
statin secretion, cysteamine increases plasma ghrelin levels
(Fukuhara et al. 2005). Ghrelin has shown to exert a central
inhibitory effect on FSH and LH secretion, as well as a
local inhibitory effect on Leydig cell proliferation and
testosterone secretion (Comninos et al. 2014). In addition,
cysteamine can potentially induce alterations of posttrans-
lational modifications in epididymal sperm (Sutovsky
2014). Furthermore, a spermicide effect of cysteamine has
been documented by a moderate reversible inhibition of
human acrosin, a protease which is released from the
acrosome of the spermatozoa in the acrosome reaction, which
is crucial to the penetration of the zona pellucida (Anderson
et al. 1998). However, whether cysteamine penetrates the
blood–testes barrier and which concentrations can be reached
in the human sperm is currently unknown.
Cystine crystal deposits and signs of increased fibrosis
have been previously demonstrated in testes in an infantile
nephropathic cystinosis patient under cysteamine therapy
(Chik et al. 1993). However, in this case, the patient had
clear signs of primary hypogonadism, sufficient to explain
his infertility. As several studies demonstrated recently that
cystinosin is involved in numerous cellular processes, one
can argue whether merely the lysosomal cystine accumula-
tion should be considered as the only pathophysiological
mechanism involved in infertility (Raggi et al. 2014; Giade
Chevronnay et al. 2015; Ivanova et al. 2015, 2016; Rega
et al. 2016). In this regard, it is of note that the cystinosin-
LKG isoform, of which its localization is not limited to the
lysosomal membrane, has the highest expression in the
testes compared to other organs (Taranta et al. 2008).
Obviously, further research is needed in order to unravel the
underlying mechanism of the azoospermia observed in
male cystinosis patients. In the meanwhile, ART can help
these patients to realize their wish of having children.
As an important subset of male cystinosis patients have
been described to evolve into a primary hypogonadism as
early as the second decade of life, sperm cryopreservation
in pubertal male cystinosis patients could be considered to
maximize their chances on fathering a child. PESA offers
the advantage of avoiding complications related to sperm
retrieval techniques at the testicular level. Moreover, the
success rate of a surgical sperm retrieval technique, like
PESA, followed by ICSI, is non-inferior in comparison to
the regular in vitro fertilization (IVF) with ejaculated semen
(Gozlan et al. 2007). It remains uncertain however, whether
the ejaculate of pubertal boys with cystinosis will contain
sperm cells that can be used for cryopreservation at all,
since this has never been tested before. Obviously, the
optimal timing at which cryopreservation would have to be
performed will raise ethical dilemmas and may also verge
on the borders of current scientific and practical feasibility.
Because of the vulnerability of this age group, the potential
emotional impact of fertility preservation and the ethical
concerns, psychological counseling should be a regular part
of a multidisciplinary team, experienced in guiding patients
through the cryopreservation and ART procedures. Ulti-
mately, the most important ethical justification for consid-
ering fertility preservation techniques in cystinosis patients
is to serve their best interests and universal needs in life.
Taken together, this first successful conception induced
by a male cystinosis patient may be considered as a
milestone and the dawn of a new era for the entire
cystinosis community.
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Take-Home Message
The first successful conception induced by a male cysti-
nosis patient, whom are known to have azoospermia of
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Details of the Contributions of Individual Authors
The Abstract, Introduction, and Discussion sections were
drafted by K. Veys and carefully revised by M. Besouw, E.
Goossens, B. van den Heuvel, and E. Levtchenko. The
Case Report section was drafted by K. D’Hauwers, A. Van
Dongen, M. Janssen, and A. Wetzels, and revised by E.
Goossens. Sequencing of the CTNS mutation of the
reported patient was performed by B. van den Heuvel.
The urologic procedures (PESA) in the reported patient
were performed by K. D’Hauwers. The fertilization
procedures were coordinated by A. Wetzels. The follow-
up of the pregnancy and delivery were managed by A. Van
Dongen. M. Janssen and E. Levtchenko are the treating




E. Levtchenko is supported by the Research Foundation –
Flanders (F.W.O. Vlaanderen), grant 1801110N, the Cysti-
nosis Research Network and Cystinosis Ireland.
K. Veys is funded by the Research Foundation –
Flanders (F.W.O. Vlaanderen), grant 11Y5216N.
Details of Ethical Approval
The procedure was performed as part of regular patient
care.
References
Anderson RA Jr, Feathergill K, Kirkpatrick R, Zaneveld LJ, Coleman
KT, Spear PG et al (1998) Characterization of cysteamine as a
potential contraceptive anti-HIV agent. J Androl 19:37–49
Besouw M, Kremer JA, Janssen MC, Levtchenko EN (2010) Fertility
status in male cystinosis patients treated with cysteamine. Fertil
Steril 93:1880–1883
Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G,
Ottolenghi C et al (2012) Cysteamine therapy delays the
progression of nephropathic cystinosis in late adolescents and
adults. Kidney Int 81:179–189
Chan AM, Lynch MJ, Bailey JD, Ezrin C, Fraser D (1970)
Hypothyroidism in cystinosis. A clinical, endocrinologic and
histologic study involving sixteen patients with cystinosis. Am J
Med 48:678–692
Chik L, Friedman A, Merriam GR, Gahl WA (1993) Pituitary-testicular
function in nephropathic cystinosis. Ann Intern Med 119:568–575
Comninos AN, Jayasena CN, Dhillo WS (2014) The relationship
between gut and adipose hormones and reproduction. Hum
Reprod Update 20:153–174
Dacheux JL, Dacheux F (2013) New insights into epididymal function
in relation to sperm maturation. Reproduction 147:2742
Fivush B, Green OC, Porter CC, Balfe JW, O’Regan S, Gahl WA
(1987) Pancreatic endocrine insufficiency in posttransplant
cystinosis. Am J Dis Child 141:1087–1089
Fivush B, Flick JA, Gahl WA (1988) Pancreatic exocrine insufficiency
in a patient with nephropathic cystinosis. J Pediatr 112:49–51
Fukuhara S, Suzuki H, Masaoka T, Arakawa M, Hosoda H, Minegishi
Y et al (2005) Enhanced ghrelin secretion in rats with
cysteamine-induced duodenal ulcers. Am J Physiol Gastrointest
Liver Physiol 289:138–145
Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med
347:111–121
Giade Chevronnay HP, Janssens V, Van Der Smissen P, Liao XH,
Abid Y, Nevo N et al (2015) A mouse model suggests two
mechanisms for thyroid alterations in infantile cystinosis:
decreased thyroglobulin synthesis due to endoplasmic reticulum
stress/unfolded protein response and impaired lysosomal pro-
cessing. Endocrinology 156:2349–2364
Gozlan I, Dor A, Farber B, Meirow D, Feinstein S, Levron J (2007)
Comparing intracytoplasmatic sperm injection and in vitro
fertilization in patients with single oocyte retrieval. Fertil Steril
87:515–518
Ivanova EA, De Leo MG, Van Den Heuvel L, Pastore A, Dijkman H,
De Matteis MA et al (2015) Endo-lysosomal dysfunction in
human proximal tubular epithelial cells deficient for lysosomal
cystine transporter cystinosin. PLoS One 10:e0120998
Ivanova EA, van den Heuvel LP, Elmonem MA, De Smedt H,
Missiaen L, Pastore A et al (2016) Altered mTOR signaling in
nephropathic cystinosis. J Inherit Metab Dis 39:457–464
Johnsen SG (1970) Testicular biopsy score count – a method for
registration of spermatogenesis in human testes: normal values
and results in 335 hypogonadal males. Hormones 1:2–25
Markello TC, Bernardini IM, Gahl WA (1993) Improved renal
function in children with cystinosis treated with cysteamine.
N Engl J Med 328:1157–1162
Pastor-Soler N, Piétrement C, Breton S (2005) Role of acid/base
transporters in the male reproductive tract and potential con-
sequences of their malfunction. Physiology (Bethesda)
20:417–428
Pholpramool C, Borwornpinyo S, Dinudom A (2011) Role of Na+/H+
exchanger 3 in the acidification of the male reproductive tract and
male fertility. Clin Exp Pharmacol Physiol 38:403–409
Raggi C, Luciani A, Nevo N, Antignac C, Terryn S, Devuyst O (2014)
Dedifferentiation and aberrations of the endolysosomal compart-
ment characterize the early stage of nephropathic cystinosis. Hum
Mol Genet 23:2266–2278
Rega LR, Polishchuk E, Montefusco S, Napolitano G, Tozzi G, Zhang
J et al (2016) Activation of the transcription factor EB rescues
lysosomal abnormalities in cystinotic kidney cells. Kidney Int
89:862–873
Schneider JA, Clark KF, Greene AA, Reisch JS, Markello TC, Gahl
WA et al (1995) Recent advances in the treatment of cystinosis.
J Inherit Metab Dis 18:387–397
JIMD Reports 5
Sutovsky P (2014) Posttranslational protein modifications in the
reproductive system. In: Sutovsky P (ed) Advances in experi-
mental medicine and biology. Springer, New York, p 759
Taranta A, Petrini S, Palma A, Mannucci L, Wilmer MJ, De Luca V
et al (2008) Identification and subcellular localization of a new
cystinosin isoform. Am J Physiol Renal Physiol 294:F1101–F1108
Taranta A, Wilmjer MJ, van den Heuvel LP, Bencivenga P, Bellomo F,
Levtchenko EN et al (2010) Analysis of CTNS gene transcripts
in nephropathic cystinosis. Pediatr Nephrol 25:1263–1267
Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA
(1976) Cystinosis. Intracellular cystine depletion by aminothiols
in vitro and in vivo. J Clin Invest 58:180–189
Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA et al
(1998) A novel gene encoding an integral membrane protein is
mutated in nephropathic cystinosis. Nat Genet 18:319–324
Weissgerber P, Kriebs U, Tsvilovskyy V, Olausson J, Kretz O,
Stoerger C et al (2011) Male fertility depends on Ca2+ absorption
by TRPV6 in epididymal epithelia. Sci Signal 4:1–13
6 JIMD Reports
